Antoni et al. [45] reported that the presence of T cells, which have the T-cell receptors to distinguish analogous tumor antigen on cancer cells, as well as the expression of PD-L1, is essential to increase treatment response to Anti-PD-L1 therapy. Here, CD274 is linked to neoplasm.